2 No-Brainer Growth Stocks to Buy Right Now

Chewy has grown annual revenue from $2.1 billion in 2018 to over $12 billion TTM, with 21 million active customers and roughly 84% of sales coming from its Autoship recurring-revenue program; the stock is down ~13% over the past year, trades at ~25x 2026 EPS estimates, and analysts project ~24% annualized earnings growth driven by pet-health services, ad revenue and membership initiatives. Dutch Bros operates 1,081 locations as of Sept. 30, 2025 with a long-term target of 7,000, reported same-store-sales growth of 5.7% and transaction growth of 4.7% in 2025, delivered 25% revenue growth year over year last quarter, and is forecast to deliver ~32% annual earnings growth while trading at ~5x sales, a multiple comparable to Starbucks in earlier growth stages.

Analysis

Market structure: Chewy (CHWY) and Dutch Bros (BROS) are direct beneficiaries — CHWY via high-visibility recurring Autoship revenue (84% of sales) and 21M active customers, BROS via unit economics as it scales from ~1,081 to a planned 7,000 stores. Losers are margin-levered, low-frequency retailers (select big-box grocers, private-label consolidators) that cede frequency and data-driven customer relationships; pricing power shifts toward subscription and branded convenience. Cross-asset: stronger recurring cash flows should modestly tighten credit spreads for high-quality retail names (lower bond yields by ~5–10bp for peers) and compress implied volatility as execution risk declines; commodity exposure (coffee beans, pet food raw materials) rises slightly with unit growth for BROS and CHWY.

Risk assessment: Tail risks include a pet-spending recession (20–30% decline in discretionary pet services), input-cost shocks for pet food, or a failed BROS franchise roll (stalling between-year openings) — any of which could cut EBITDA by >20% in 12 months. Short-term (days–weeks): watch Autoship retention and monthly same-store-sales; medium-term (3–12 months): ad monetization and Chewy Plus uptake; long-term (1–3 years): margin convergence if competitors replicate Autoship or labor/real-estate costs outpace sales. Hidden dependencies: CHWY’s margin story hinges on ad/health-service take rates and CPM stability; BROS depends on unit-level labor productivity and fill rates.

Trade implications: Direct: establish a 2–3% portfolio long in CHWY for a 12–24 month horizon targeting 40–60% upside if analyst EPS CAGR ~24% materializes; establish 1–2% long in BROS as a multi-year growth play, but size smaller due to execution risk. Pair: long CHWY / short PETS (Petco, PETS) 1:1 to isolate Autoship/recurring revenue vs. brick-and-mortar risk. Options: buy CHWY Jan 19, 2027 LEAP calls ~25% OTM or call spreads (buy Jan 2027 25% OTM, sell Jan 2027 60% OTM) to limit premium; for BROS use 9–12 month call spreads around expected quarterly comp prints. Entry: DCA over 4–8 weeks; stops at 12–15% and trim into strength at +40%.

Contrarian angles: The market may underappreciate CHWY’s ability to monetize health services and sponsored ads — if ad revenue reaches even 2–3% of sales in 18 months, EPS could re-rate >30%. Conversely, consensus may be too sanguine on BROS margins; historical parallels to early Starbucks suggest multiple expansion is possible but only after a durable margin inflection; unintended consequences include competitors adopting Autoship-like subs, compressing CHWY’s premium—hedge size accordingly. Catalysts to watch that could flip positions: CHWY Autoship churn delta >+200bps in a quarter, BROS new-store productivity below walk-rate by >10% for two consecutive quarters, or material CPM decline for digital pet ads.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in CHWY (buy shares in tranches over 4–8 weeks). Target 40–60% upside over 12–24 months if EPS CAGR ~24% proves out; place a hard stop at 15% drawdown and reassess if Autoship retention falls >200bps in any quarter.
• Initiate a smaller 1–2% long position in BROS for multi-year upside from unit growth; size exposure conservatively and use a 12-month call spread (buy Mar 17, 2027 calls 25% OTM, sell Mar 17, 2027 calls 60% OTM) to cap premium while keeping upside exposure.
• Implement a pair trade: long CHWY / short PETS (Petco) 1:1 sized at net 1–2% of portfolio to isolate recurring-revenue vs. brick-and-mortar risk; rebalance if relative performance deviates >10% over 60 days.
• Buy CHWY Jan 19, 2027 LEAP calls ~25% OTM (or equivalent call spread) for asymmetric upside; allocate no more than 0.5–1% of portfolio to options and hedge by reducing option size if implied vol spikes >30% versus 30‑day historical.
• Reduce exposure to low-margin, non-subscription big-box competitors by 2–3% and reallocate to CHWY/BROS themes; reassess within 90 days around quarterly prints — specifically monitor CHWY Autoship % and AD monetization KPIs and BROS same-store-sales and new-store productivity for signs to double down or cut.